Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental and care coordination solutions. Further, it provides tech-enabled services, such as implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third-party administrator services; and complementary hardware and devices for third parties. The company serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.
IPO Year: 1986
Exchange: NASDAQ
Website: cerner.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/11/2022 | Buy → Hold | Argus | |
| 12/22/2021 | Overweight → Sector Weight | Keybanc | |
| 12/21/2021 | $85.00 → $95.00 | Equal-Weight | Morgan Stanley |
| 12/21/2021 | $86.00 → $95.00 | Outperform → Sector Perform | RBC Capital |
| 12/21/2021 | $88.00 → $95.00 | Outperform → Market Perform | SVB Leerink |
| 12/20/2021 | $77.00 → $85.00 | Underweight → Equal-Weight | Morgan Stanley |
| 11/17/2021 | $82.00 | Neutral | Robert W. Baird |
| 11/17/2021 | $82.00 | Neutral | Baird |
| 11/1/2021 | $77.00 → $79.00 | Equal-Weight | Barclays |
| 8/31/2021 | $70.00 → $75.00 | Underweight | Morgan Stanley |
15-12G - CERNER Corp (0000804753) (Filer)
S-8 POS - CERNER Corp (0000804753) (Filer)
S-8 POS - CERNER Corp (0000804753) (Filer)
S-8 POS - CERNER Corp (0000804753) (Filer)
S-8 POS - CERNER Corp (0000804753) (Filer)
S-8 POS - CERNER Corp (0000804753) (Filer)
S-8 POS - CERNER Corp (0000804753) (Filer)
S-8 POS - CERNER Corp (0000804753) (Filer)
S-8 POS - CERNER Corp (0000804753) (Filer)
S-8 POS - CERNER Corp (0000804753) (Filer)
Argus downgraded Cerner from Buy to Hold
Keybanc downgraded Cerner from Overweight to Sector Weight
Morgan Stanley reiterated coverage of Cerner with a rating of Equal-Weight and set a new price target of $95.00 from $85.00 previously
RBC Capital downgraded Cerner from Outperform to Sector Perform and set a new price target of $95.00 from $86.00 previously
SVB Leerink downgraded Cerner from Outperform to Market Perform and set a new price target of $95.00 from $88.00 previously
Morgan Stanley upgraded Cerner from Underweight to Equal-Weight and set a new price target of $85.00 from $77.00 previously
Robert W. Baird initiated coverage of Cerner with a rating of Neutral and set a new price target of $82.00
Baird initiated coverage of Cerner with a rating of Neutral and set a new price target of $82.00
Barclays reiterated coverage of Cerner with a rating of Equal-Weight and set a new price target of $79.00 from $77.00 previously
Morgan Stanley reiterated coverage of Cerner with a rating of Underweight and set a new price target of $75.00 from $70.00 previously
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the
Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market. "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longs
AUSTIN, Texas, June 7, 2022 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) announced that a majority of the outstanding shares (the "Shares") of Cerner Corporation (NASDAQ:CERN) were validly tendered, and the other conditions to the tender offer have been satisfied or waived. The deal will close on June 8, 2022. American Stock Transfer & Trust Company LLC, the depositary for the tender offer, has indicated that as of 12:00 midnight, Eastern time, at the end of the day on June 6, 2022, approximately 204,280,589 Shares, or 69.2% of the total Shares, have been validly tendered.
NEW YORK, June 3, 2022 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices: VICI Properties Inc. (NYSE:VICI) will replace Cerner Corp. (NASD: CERN) in the S&P 500 prior to the open of trading on Wednesday, June 8. S&P 500 constituent Oracle Corp. (NYSE:ORCL) is acquiring Cerner in a deal expected to be completed soon.The following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 are being made to ensure each index is more representative of its market capitalization range. These changes will be effective prior to the open of trading on Tuesday, June 21, (post close on Friday, June 17) to coinc
The company's Learning Health Network teams with Elligo Health Research and Freenome to Advance Early Cancer Detection KANSAS CITY, Mo., May 18, 2022 /PRNewswire/ -- Cerner Corporation (NASDAQ:CERN), Elligo Health Research® and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection. Together they will be using the research-activated network of health systems, real-world data (RWD) and multiomics technology, developed by Freenome, with the goal to help accelerate early cancer detection. This will be one
AUSTIN, Texas, May 10, 2022 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) ("Oracle") announced today that it has extended its tender offer in connection with the acquisition of Cerner Corporation (NASDAQ:CERN) ("Cerner") until June 6, 2022. In accordance with the terms of its merger agreement with Cerner, Cedar Acquisition Corporation, a subsidiary of OC Acquisition LLC, which is a subsidiary of Oracle, has extended the all-cash tender offer for $95.00 per share for all of the issued and outstanding shares of common stock of Cerner (the "Shares") to 12:00 midnight, Eastern Ti
Margin Expansion Drives Strong Earnings Growth KANSAS CITY, Mo., May 3, 2022 /PRNewswire/ -- Cerner Corporation (NASDAQ:CERN) today announced results for the 2022 first quarter that ended March 31, 2022. The first quarter earnings release can be viewed here as well as on the company's website at https://investors.cerner.com/financial-releases. About Cerner Cerner's health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally
AUSTIN, Texas, April 11, 2022 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) ("Oracle") announced today that it has extended its tender offer in connection with the acquisition of Cerner Corporation (NASDAQ:CERN) ("Cerner") until May 11, 2022. In accordance with the terms of its merger agreement with Cerner, Cedar Acquisition Corporation, a subsidiary of OC Acquisition LLC, which is a subsidiary of Oracle, has extended the all-cash tender offer for $95.00 per share for all of the issued and outstanding shares of common stock of Cerner (the "Shares") to 12:00 midnight, Eastern
Companies expand their existing collaboration to integrate Nuance DAX technology that is simpler for clinicians to use and eases clinical documentation burden ORLANDO, Fla., March 16, 2022 /PRNewswire/ -- At the HIMSS Global Health Conference & Exhibition, Nuance® Communications, Inc. and Cerner Corporation (NASDAQ:CERN) announced that they have expanded their collaboration to integrate the Nuance® Dragon® Ambient eXperience™ (DAX™) system into the Cerner Millennium® electronic health record (EHR). The collaboration deepens the existing integration of Nuance and Cerner technologies and is expected to help manage administrative workloads that lead to clinician burnout, expand access to car
KANSAS CITY, Mo., March 15, 2022 /PRNewswire/ -- Cerner Corporation (NASDAQ:CERN), a global healthcare technology company, today announced that its Board of Directors (the "Board") declared a cash dividend to stockholders of $0.27 per issued and outstanding share. The cash dividend will be payable April 19, 2022, to shareholders of record as of the close of business March 28, 2022. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to Board approval and their determination that the declaration of dividends remains in the best interests of
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the
Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market. "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longs
CALGARY, AB, Jan. 25, 2022 /CNW/ - Comprehensive Healthcare Systems Inc. (TSXV:CHS) (the "Company" or "CHS"), an industry leader in Healthcare Benefits Administration software and services, is pleased to announce the appointment of Chris Cosgrove as the Company's new President and Chief Executive Officer ("CEO") and to its board of directors effective February 1, 2022. Mr. Cosgrove has 25 years of management and leadership experience in the healthcare technology industry and will replace CHS founder, Dr. Hassan Mohaideen, who will continue in his role as Chairman of the board of directors (the "Board") and be appointed Chief Medical Officer of the Company. "With a proven track record of lea
Better Therapeutics, Inc. (("Better Therapeutics", NASDAQ:BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of Major General Elder Granger, M.D., U.S. Army (retired) to its board of directors. "Dr. Granger's track record of leadership in navigating complex policy, regulatory and competitive environments will be welcome additions to the Better Therapeutics board," said David Perry, co-founder and chairman of Better Therapeutics. "His extensive board experience coupled with an unwavering commitment to improving the delivery of healthcare will be invaluable as we wo
Highly Accomplished Visionary with Proven Track Record of Leading Healthcare Businesses Cerner Board Separates Chairman and CEO Roles and Names William Zollars Chairman of Board of Directors KANSAS CITY, Mo., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN) today announced that its Board of Directors has appointed David Feinberg, M.D., MBA, as President and Chief Executive Officer, effective October 1, 2021. He succeeds Brent Shafer, who previously announced his decision to transition from chairman and CEO. Dr. Feinberg will serve as a member of the Board of Directors. Cerner's current President, Donald Trigg, will leave Cerner. Cerner's Board of Directors also announ
KANSAS CITY, Mo., March 15, 2022 /PRNewswire/ -- Cerner Corporation (NASDAQ:CERN), a global healthcare technology company, today announced that its Board of Directors (the "Board") declared a cash dividend to stockholders of $0.27 per issued and outstanding share. The cash dividend will be payable April 19, 2022, to shareholders of record as of the close of business March 28, 2022. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to Board approval and their determination that the declaration of dividends remains in the best interests of
KANSAS CITY, Mo., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN), a global healthcare technology company, today announced that its board of directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable January 11, 2022, to shareholders of record as of the close of business December 27, 2021. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to Board approval and their determination that the declaration of dividends remains in the best interests of Cerner and its shareholders. The decision of whether to pay fu
Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed here as well as on the company's website at https://investors.cerner.com/financial-releases. Cerner will host an earnings conference call to provide additional detail on the Company's results and outlook at 8:00 a.m. CT on October 29, 2021. On the call, Cerner will disc
KANSAS CITY, Mo., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN) today announced it will release its third quarter 2021 earnings results before the market opens Friday, Oct. 29. Following the release, the company will hold a conference call at 8 a.m. CT that can be accessed via dial-in or webcast. On the call, Cerner will discuss its results and outlook and answer questions from the investment community. The call may also include discussion of Cerner developments and other material and forward-looking information about business and financial matters. The dial-in number for the conference call is (678) 509-7542; the passcode is Cerner. The company recommends joining the
KANSAS CITY, Mo., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN), a global healthcare technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.22 per issued and outstanding share. The cash dividend will be payable on October 12, 2021, to shareholders of record as of the close of business on September 27, 2021. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to Board approval and their determination that the declaration of dividends remains in the best interests of Cerner and its shareholders. The decision of whether to pay future dividends and the amount of any such dividend
Delivers Strong Results Across All Key MetricsGAAP Operating Margin and Diluted EPS Lower Due to Restructuring ChargesStrong Adjusted Operating Margin Expansion and Adjusted Diluted EPS Growth vs. Year Ago Quarter KANSAS CITY, Mo., July 30, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN) today announced results for the 2021 second quarter that ended June 30, 2021. The second quarter 2021 earnings release can be viewed here as well as on the company's website at https://investors.cerner.com/financial-releases. Cerner will host an earnings conference call to provide additional detail on the Company's results and outlook at 8 a.m. CT on July 30, 2021. On the call, Cerner will dis
KANSAS CITY, Mo., May 19, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.22 per issued and outstanding share. The cash dividend will be payable on July 13, 2021, to shareholders of record as of the close of business on June 28, 2021. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to Board approval and their determination that the declaration of dividends remains in the best interests of Cerner and its shareholders. The decision of whether to pay future dividends and the amount of any such dividends will be
KANSAS CITY, Mo., April 01, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ: CERN), a global healthcare technology company, today announced the acquisition of Kantar Health, a division of Kantar Group, for $375 million in cash, subject to adjustment. Kantar Health’s rich life sciences expertise will be combined with Cerner’s robust collection of real-world data (RWD) and technology and is expected to accelerate innovation in life sciences research and improve patient outcomes worldwide. “The promise of real-world evidence to power drug discovery is right in front of us,” said Donald Trigg, president, Cerner. “Kantar Health is an important next step in building out the capabilities ou
KANSAS CITY, Mo., March 26, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.22 per issued and outstanding share. The cash dividend will be payable on April 20, 2021, to shareholders of record as of the close of business on April 6, 2021. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to Board approval and their determination that the declaration of dividends remains in the best interests of Cerner and its shareholders. The decision of whether to pay future dividends and the amount of any such dividends wi
KANSAS CITY, Mo., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.22 per issued and outstanding share, up 22% from the prior quarterly dividend of $0.18. The cash dividend will be payable on Jan. 12, 2021, to shareholders of record as of the close of business on Dec. 28, 2020. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to Board approval and their determination that the declaration of dividends remains in the best interests of Cerner and its shareholders. The decision of whether to pay future d
4 - CERNER Corp (0000804753) (Issuer)
4 - CERNER Corp (0000804753) (Issuer)
4 - CERNER Corp (0000804753) (Issuer)
4 - CERNER Corp (0000804753) (Issuer)
4 - CERNER Corp (0000804753) (Issuer)
4 - CERNER Corp (0000804753) (Issuer)
4 - CERNER Corp (0000804753) (Issuer)
4 - CERNER Corp (0000804753) (Issuer)
4 - CERNER Corp (0000804753) (Issuer)
4 - CERNER Corp (0000804753) (Issuer)
SC 13G/A - CERNER Corp (0000804753) (Subject)
SC 13G/A - CERNER Corp (0000804753) (Subject)